Related references
Note: Only part of the references are listed.Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi et al.
NATURE (2017)
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
Susana V. Bardina et al.
SCIENCE (2017)
IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity
Taia T. Wang et al.
SCIENCE (2017)
Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope
Alexander Rouvinski et al.
NATURE COMMUNICATIONS (2017)
Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells
J. L. Slon Campos et al.
SCIENTIFIC REPORTS (2017)
Modified mRNA Vaccines Protect against Zika Virus Infection
Justin M. Richner et al.
CELL (2017)
Structural Basis of Zika Virus-Specific Antibody Protection
Haiyan Zhao et al.
CELL (2016)
Structural basis of potent Zika-dengue virus antibody cross-neutralization
Giovanna Barba-Spaeth et al.
NATURE (2016)
Vaccine protection against Zika virus from Brazil
Rafael A. Larocca et al.
NATURE (2016)
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus
Wanwisa Dejnirattisai et al.
NATURE IMMUNOLOGY (2016)
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus
Lalita Priyamvada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Rapid development of a DNA vaccine for Zika virus
Kimberly A. Dowd et al.
SCIENCE (2016)
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys
Peter Abbink et al.
SCIENCE (2016)
The 3.8 Å resolution cryo-EM structure of Zika virus
Devika Sirohi et al.
SCIENCE (2016)
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection
Karin Stettler et al.
SCIENCE (2016)
Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus
J. A. Swanstrom et al.
MBIO (2016)
Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice
Chen-Yi Chiang et al.
SCIENTIFIC REPORTS (2016)
Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity
Kuan Rong Chan et al.
NATURE MICROBIOLOGY (2016)
Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation
Eun Kim et al.
EBIOMEDICINE (2016)
Secretion of dengue virus envelope protein ectodomain from mammalian cells is dependent on domain II serotype and affects the immune response upon DNA vaccination
J. L. Slon Campos et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Recognition determinants of broadly neutralizing human antibodies against dengue viruses
Alexander Rouvinski et al.
NATURE (2015)
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
S. R. Hadinegoro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
Luis Villar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nucleic acid (DNA) immunization as a platform for dengue vaccine development
Kevin R. Porter et al.
VACCINE (2015)
Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes
Monica Poggianella et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response
Jacky Flipse et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
Wanwisa Dejnirattisai et al.
NATURE IMMUNOLOGY (2015)
Zika Virus Outbreak, Bahia, Brazil
Gubio S. Campos et al.
EMERGING INFECTIOUS DISEASES (2015)
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
Maria Rosario Capeding et al.
LANCET (2014)
Dengue Viruses Are Enhanced by Distinct Populations of Serotype Cross-Reactive Antibodies in Human Immune Sera
Ruklanthi de Alwis et al.
PLOS PATHOGENS (2014)
Mouse models to study dengue virus immunology and pathogenesis
Raphael M. Zellweger et al.
FRONTIERS IN IMMUNOLOGY (2014)
Mechanistic Study of Broadly Neutralizing Human Monoclonal Antibodies against Dengue Virus That Target the Fusion Loop
Joshua M. Costin et al.
JOURNAL OF VIROLOGY (2013)
Functional Analysis of Antibodies against Dengue Virus Type 4 Reveals Strain-Dependent Epitope Exposure That Impacts Neutralization and Protection
Soila Sukupolvi-Petty et al.
JOURNAL OF VIROLOGY (2013)
The global distribution and burden of dengue
Samir Bhatt et al.
NATURE (2013)
Dengue Virus Neutralization in Cells Expressing Fc Gamma Receptors
Tanu Chawla et al.
PLOS ONE (2013)
Correlation between Dengue-Specific Neutralizing Antibodies and Serum Avidity in Primary and Secondary Dengue Virus 3 Natural Infections in Humans
Andreas Puschnik et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Dissection of Antibody Specificities Induced by Yellow Fever Vaccination
Oksana Vratskikh et al.
PLOS PATHOGENS (2013)
CURRENT CONCEPTS Dengue
Cameron P. Simmons et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
Ruklanthi de Alwis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Antibody-mediated neutralization of flaviviruses: A reductionist view
Kimberly A. Dowd et al.
VIROLOGY (2011)
The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
Martina Beltramello et al.
CELL HOST & MICROBE (2010)
A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation
Dorothy Beckett et al.
PROTEIN SCIENCE (2010)
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Wanwisa Dejnirattisai et al.
SCIENCE (2010)
Report of an NIAID workshop on dengue animal models
M. Cristina Cassetti et al.
VACCINE (2010)
A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice
Olivia K. T. Block et al.
VACCINE (2010)
The Complexity of Antibody-Dependent Enhancement of Dengue Virus Infection
Maria G. Guzman et al.
VIRUSES-BASEL (2010)
Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
W. M. P. B. Wahala et al.
VIROLOGY (2009)
In vivo site-specific biotinylation of proteins within the secretory pathway using a single vector system
Andrea Predonzani et al.
BMC BIOTECHNOLOGY (2008)
Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus
Gregory D. Gromowski et al.
JOURNAL OF VIROLOGY (2008)
The stoichiometry of antibody-mediated neutralization and enhancement of west nile virus infection
Theodore C. Pierson et al.
CELL HOST & MICROBE (2007)
Antibody recognition and neutralization determinants on domains I and II of West Nile virus envelope protein
Theodore Oliphant et al.
JOURNAL OF VIROLOGY (2006)
Characterization of neutralizing antibodies to West Nile virus
MD Sánchez et al.
VIROLOGY (2005)
Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein
Y Modis et al.
JOURNAL OF VIROLOGY (2005)
Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections
VAUF de Souza et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion
RJ Kuhn et al.
CELL (2002)
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells
WD Crill et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
